rs109077
|
PPARGC1B
|
Basal Cell Cancer
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
rs109077
|
PPARGC1B
|
Basal cell carcinoma
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
rs109077
|
PPARGC1B
|
Basal Cell Neoplasm
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
rs251464
|
PPARGC1B
|
Malignant melanoma of skin of upper limb
|
|
0.700 |
GeneticVariation |
GWASCAT |
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
|
30429480 |
2018 |
rs251464
|
PPARGC1B
|
Cutaneous Melanoma
|
|
0.700 |
GeneticVariation |
GWASCAT |
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
|
30429480 |
2018 |
rs251464
|
PPARGC1B
|
Suntan
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposure.
|
29739929 |
2018 |
rs251464
|
PPARGC1B
|
Malignant melanoma of skin of lower limb
|
|
0.700 |
GeneticVariation |
GWASCAT |
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
|
30429480 |
2018 |
rs251468
|
PPARGC1B
|
Melanosis
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations.
|
29895819 |
2018 |
rs251464
|
PPARGC1B
|
Vitiligo
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
|
27723757 |
2016 |
rs17110429
|
PPARGC1B
|
Low density lipoprotein cholesterol measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
rs17110429
|
PPARGC1B
|
Serum LDL cholesterol measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
rs9285640
|
PPARGC1B
|
response to fenofibrate
|
G |
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate.
|
22890011 |
2012 |
rs7732671
|
PPARGC1B
|
Breast Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
Pro 12Ala and Ala203Pro polymorphisms did not modify the association between the iAs methylation capacity and BC.
|
27557380 |
2016 |
rs7732671
|
PPARGC1B
|
Malignant neoplasm of breast
|
|
0.020 |
GeneticVariation |
BEFREE |
Pro 12Ala and Ala203Pro polymorphisms did not modify the association between the iAs methylation capacity and BC.
|
27557380 |
2016 |
rs7732671
|
PPARGC1B
|
Malignant neoplasm of breast
|
|
0.020 |
GeneticVariation |
BEFREE |
The genotype-combination analysis of the associated PPARGC1A Thr612Met variant and the associated PPARGC1B Ala203Pro variant suggests an allele dose-dependent breast cancer risk (P(trend) = 0.0004).
|
16704985 |
2006 |
rs7732671
|
PPARGC1B
|
Breast Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
The genotype-combination analysis of the associated PPARGC1A Thr612Met variant and the associated PPARGC1B Ala203Pro variant suggests an allele dose-dependent breast cancer risk (P(trend) = 0.0004).
|
16704985 |
2006 |
rs1076064
|
PPARGC1B;MIR378A
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
Since miRNA-based mechanisms are shown to be involved in the pathogenesis of prostate cancer (PCa), the aim of the present study was to evaluate the effect of rs4938723, rs1076064 and rs4705343 occurring in regulatory regions of miR-34b/c, miR-143/145 and miR-378, respectively, on PCa risk and progression in Serbian population.
|
31423132 |
2019 |
rs1076064
|
PPARGC1B;MIR378A
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Since miRNA-based mechanisms are shown to be involved in the pathogenesis of prostate cancer (PCa), the aim of the present study was to evaluate the effect of rs4938723, rs1076064 and rs4705343 occurring in regulatory regions of miR-34b/c, miR-143/145 and miR-378, respectively, on PCa risk and progression in Serbian population.
|
31423132 |
2019 |
rs17572019
|
PPARGC1B
|
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
We selected the <i>PPARG</i> rs3856806 C>T, <i>PPARGC1A</i> rs2970847 C>T, rs8192678 C>T, rs3736265 G>A and <i>PPARGC1B</i> rs7732671 G>C and rs17572019 G>A SNPs to assess the relationship between <i>PPARG, PPARGC1A, PPARGC1B</i> their variants and risk of CRC.
|
30838172 |
2019 |
rs17572019
|
PPARGC1B
|
Liver carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
In this study, we selected <i>PPARG</i> rs1801282 C>G and rs3856806 C>T, <i>PPARGC1A</i> rs2970847 C>T, and <i>PPARGC1B</i> rs7732671 G>C and rs17572019 G>A single-nucleotide polymorphisms to explore the relationship between these polymorphisms and hepatocellular carcinoma (HCC) risk.
|
30122956 |
2018 |
rs62382272
|
PPARGC1B;MIR378A
|
Malignant neoplasm of breast
|
|
0.010 |
GeneticVariation |
BEFREE |
After multivariate logistic regression analysis, we found that three CpG-SNPs: rs1190983, rs155247, and rs62382272, were significantly associated with breast-cancer susceptibility in the population (Additive model: rs1190983: adjusted OR = 0.88, 95% CI: 0.79-0.99, P = 0.034; rs155247: adjusted OR = 0.83, 95% CI: 0.74-0.93, P = 0.002; rs62382272: adjusted OR = 1.24, 95% CI: 1.04-1.47, P = 0.016). eQTL analysis showed that these three SNPs were correlated with the expression of the related miRNAs in TCGA breast cancer tissues (P = 0.006,0.009,0.001 for rs1190983, rs155247, and rs62382272).
|
29374520 |
2018 |
rs62382272
|
PPARGC1B;MIR378A
|
Breast Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
After multivariate logistic regression analysis, we found that three CpG-SNPs: rs1190983, rs155247, and rs62382272, were significantly associated with breast-cancer susceptibility in the population (Additive model: rs1190983: adjusted OR = 0.88, 95% CI: 0.79-0.99, P = 0.034; rs155247: adjusted OR = 0.83, 95% CI: 0.74-0.93, P = 0.002; rs62382272: adjusted OR = 1.24, 95% CI: 1.04-1.47, P = 0.016). eQTL analysis showed that these three SNPs were correlated with the expression of the related miRNAs in TCGA breast cancer tissues (P = 0.006,0.009,0.001 for rs1190983, rs155247, and rs62382272).
|
29374520 |
2018 |
rs7732671
|
PPARGC1B
|
Liver carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
In this study, we selected <i>PPARG</i> rs1801282 C>G and rs3856806 C>T, <i>PPARGC1A</i> rs2970847 C>T, and <i>PPARGC1B</i> rs7732671 G>C and rs17572019 G>A single-nucleotide polymorphisms to explore the relationship between these polymorphisms and hepatocellular carcinoma (HCC) risk.
|
30122956 |
2018 |
rs17572019
|
PPARGC1B
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
Haplotype comparison analysis indicated that CTTCGGG and CTCTGGG haplotypes with the order of PPARG rs1801282 C>G, PPARG rs3856806 C>T, PPARGC1A rs8192678 C>T, PPARGC1A rs2970847 C>T, PPARGC1A rs3736265 G>A, PPARGC1B rs7732671 G>C and PPARGC1B rs17572019 G>A polymorphisms in gene position significantly increased the risk of T2DM.
|
28418876 |
2017 |
rs7732671
|
PPARGC1B
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
Haplotype comparison analysis indicated that CTTCGGG and CTCTGGG haplotypes with the order of PPARG rs1801282 C>G, PPARG rs3856806 C>T, PPARGC1A rs8192678 C>T, PPARGC1A rs2970847 C>T, PPARGC1A rs3736265 G>A, PPARGC1B rs7732671 G>C and PPARGC1B rs17572019 G>A polymorphisms in gene position significantly increased the risk of T2DM.
|
28418876 |
2017 |